SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 226 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $6,600,000 | +9.3% | 226,345 | 0.0% | 0.05% | +2.2% |
| Q3 2021 | $6,037,000 | -19.8% | 226,345 | -7.4% | 0.05% | -17.9% |
| Q2 2021 | $7,526,000 | +13.6% | 244,433 | -3.4% | 0.06% | +12.0% |
| Q1 2021 | $6,623,000 | -0.9% | 252,989 | -4.7% | 0.05% | -9.1% |
| Q4 2020 | $6,681,000 | +42.7% | 265,551 | +18.2% | 0.06% | +19.6% |
| Q3 2020 | $4,681,000 | +78.1% | 224,603 | +167.4% | 0.05% | +170.6% |
| Q1 2017 | $2,629,000 | +19.7% | 83,985 | -3.4% | 0.02% | +21.4% |
| Q4 2016 | $2,197,000 | -22.0% | 86,981 | -23.6% | 0.01% | -26.3% |
| Q3 2016 | $2,817,000 | +18.3% | 113,880 | -2.6% | 0.02% | +18.8% |
| Q2 2016 | $2,382,000 | +7.2% | 116,898 | -19.8% | 0.02% | +6.7% |
| Q1 2016 | $2,222,000 | -1.3% | 145,675 | -13.0% | 0.02% | +7.1% |
| Q4 2015 | $2,252,000 | +1701.6% | 167,520 | +1795.0% | 0.01% | +1300.0% |
| Q3 2015 | $125,000 | -7.4% | 8,840 | +11.3% | 0.00% | 0.0% |
| Q2 2015 | $135,000 | – | 7,940 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |